Short-Term Effects of Tolvaptan in Patients With Acute Heart Failure and Volume Overload

Overview of attention for article published in JACC, March 2017

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (92nd percentile)
Good Attention Score compared to outputs of the same age and source (69th percentile)

Mentioned by

blogs: 1 blog
policy: 1 policy source
twitter: 23 X users

facebook: 2 Facebook pages
guideline: 1 clinical guideline source

Readers on

mendeley: 167 Mendeley

So far, Altmetric has seen 3 public wall posts from 2 users.

Asociación Colombiana de Medicina Interna, 17 Mar 2017

Tolvaptan – a drug for CHF which may need tighter patient selection – see more #JACC http://ow.ly/7jJp309YKA0 pic.twitter.com/nq…

Asociación Colombiana de Medicina Interna, 16 Mar 2017

How does tolvaptan fare in dyspnea relief for CHF patients? #JACC http://ow.ly/qxFj309YKbt pic.twitter.com/aShhRiIpCy

JACC Journals - Journals of the American College of Cardiology, 16 Mar 2017

Editors' Insights: Tolvaptan did not improve short term dyspnea in CHF patients, but in some, there was improvement later in…

This page shows the most recent Facebook posts that mention this research output. Click here to find out how to access more activity.